Post-COVID-19 condition (PCC) involves persistent symptoms like fatigue and cognitive dysfunction, affecting 8.4% of US adults. A randomized clinical trial showed cognitive and behavioral ...

Canine Cognitive Dysfunction (CCD) is a neurodegenerative syndrome affecting aged dogs and is considered the animal counterpart to human dementia, particularly Alzheimer’s disease. CCD manifests as ...

Low-dose lithium aspartate did not improve fatigue and cognitive dysfunction symptoms in long COVID. A small dose-finding study suggested higher doses might be effective, but a new trial is needed.

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Vielight Neuro RX Gamma device and irradiation configuration used in the randomized, double-blind, sham-controlled trial. The ...

A recent neuropsychological evaluation diagnosis impugned several controversial theories about anesthesia and cognitive decline. As a medicinal therapy to relieve pain and brain dysfunction, ...

Studying the possible association between AI and cognitive dysfunction has accelerated over the past 7 years. A pilot study using neuropsychological testing from the Arimidex, Tamoxifen, Alone or in ...

Study identifies plasma free-carnitine deficiency in women with aMCI and early-AD, highlighting mitochondrial metabolism as a target for individualized preventive treatments. Study: Sex differences in ...

Table 1. Summary of medical therapy (chemotherapy and aromatase inhibitors) and measurements of cognitive functioning (neuropsychological testing and functional imaging) and potential confounders ...